Dec. 14, 2018 Price forecast | 2 weeks: 5.32% | 1 month: 6.43% | 3 months: 4.85%


AGTC stock forecast

Our latest prediction for Applied Genetic Technologies Corp.'s stock price was made on the Dec. 14, 2018 when the stock price was at 3.25$.

In the short term (2weeks), AGTC's stock price should outperform the market by 5.32%. During that period the price should oscillate between -8.72% and +19.84%.

In the medium term (3months), AGTC's stock price should outperform the market by 4.85%. During that period the price should oscillate between -18.49% and +42.90%.


About Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. engages in the development of gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. It has clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL.

At the moment the company generates 28M USD in revenues.

On its last earning announcement, the company reported a loss of -0.82$ per share.

The book value per share is 5.47$

Applied Genetic Technologies Corp. website


Three months stock forecastDec. 14, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
28M - -17M -61.80% -15M -0.82 - - 18M 5.47 -35M -1M -35M